No-Cost, No-Obligation Zantac Cancer Attorney Case Review

Antacid Cancer Attorney
Zantac Lawsuit News

Zantac May Cause Type-2 Diabetes As Well As Many Types of Cancer

New studies are coming out that indicate Zantac and other PPI drugs like Prilosec and Nexium may cause diabetes

Wednesday, October 21, 2020 - Thousands of individuals with a variety of cancer, including stomach, bladder, and esophagus cancer, are alleging that Zantac, the world's best-selling heartburn and acid reflux medicine caused the disease. Many are hiring a Zantac Cancer Lawyer to help them file a claim against the drug manufacturer for failing to warn them of the alleged cancer danger. In addition to causing cancer, Zantac, and all drugs in the ranitidine and PPI class are suspected of also contributing to the worldwide type-2 diabetes epidemic. A recent study coming out of China is purporting that using Zantac regularly and for more than a year or two can increase one's chances of developing type-2 diabetes. The website Chemical Market Reports tells readers that scientists from Sun Yat-sen University in China have released the results of a study concluding, "people who have been consuming acid reflux drugs might be at a 24 percent higher risk of being diagnosed with type 2 diabetes. Experts have warned people saying that those who are taking proton pump inhibitors (PPI) are twice more likely to be diagnosed with type 2 diabetes." The study followed over 200,000 diabetes-free people and concluded that the longer one uses one of these heartburn medicines, the higher the chances of developing diabetes.

Another study indicates that veterans of the Vietnam War may have contracted cancer of the stomach, bladder, esophagus, and others from taking the anti-heartburn and acid reflux medication Zantac. When the China study is considered, veterans may also be developing diabetes from taking Zantac. Vietnam Veterans are prone to developing diabetes Mellitus and take type-2 diabetes medicine metformin to try and control their blood sugar. Along with Zantac, metformin has been tested and shown to contain high levels of N-nitrosodimethylamine (NDMA), a cancer-causing agent. When the two are combined, Vietnam Veterans that have diabetes are more inclined to develop cancer. According to the NW Herald, Michael A. Iwanicki, superintendent of the McHenry County Veterans Assistance Commission told reporters, "veterans exposed to Agent Orange are prone to developing Type 2 diabetes mellitus, and persons with diabetes mellitus seem to be more likely to develop bladder cancer." Military Veterans may be more susceptible to developing cancer and diabetes from having used Zantac than the general population.

Sanofi, the maker of Zantac, is being accused of covering up what they knew of Zantac's NDMA cancer problem. Plaintiffs suing the company allege that Sanofi knew or had the responsibility to know that levels of carcinogenic NDMA could rise to dangerous levels when exposed to high storage temperatures when mixed with the meat preservative nitrite in the stomach, or potentially compromised at the source where it is manufactured in China and elsewhere. If you or a loved one have developed cancer and have taken Zantac you should speak with a Zantac Cancer Lawyer.

More Recent Heartburn MedicineLawsuit News:

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.